FDA — authorised 4 June 2014
- Application: NDA204399
- Marketing authorisation holder: UPSHER SMITH LABS
- Local brand name: VOGELXO
- Indication: GEL — TRANSDERMAL
- Status: approved
FDA authorised Vogelxo on 4 June 2014
Yes. FDA authorised it on 4 June 2014; FDA has authorised it.
UPSHER SMITH LABS holds the US marketing authorisation.